Oakworth Capital Inc. Sells 271 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Oakworth Capital Inc. cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,692 shares of the exchange traded fund’s stock after selling 271 shares during the period. Oakworth Capital Inc.’s holdings in SPDR S&P Biotech ETF were worth $513,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of XBI. Avior Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC boosted its position in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the period. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $40,000. ORG Wealth Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $44,000. Finally, Howe & Rusling Inc. bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $49,000.

SPDR S&P Biotech ETF Trading Up 2.3 %

XBI opened at $94.70 on Thursday. The company has a market cap of $7.22 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The company’s 50 day moving average is $92.88 and its 200 day moving average is $96.57.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.